Opposing functions of Akt isoforms in lung tumor initiation and progression

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Linnerth Petrik, Nicolle M ^a   Santry, Lisa A ^a   Petrik, James J ^a   Wootton, Sarah K ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA NUCLEOTIDYLEXOTRANSFERASE; ISOPROTEIN; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GROWTH ACCELERATION; GROWTH RATE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LUNG TUMOR; MALE; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; TUMOR GROWTH; VIRUS ONCOGENE; ANIMAL; DISEASE COURSE; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84899533121     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094595     Document Type: Article

References (66)

1. Liu SL, Miller AD (2007) Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein. Oncogene 26: 789-801.
2. Mornex JF, Thivolet F, De las Heras M, Leroux C (2003) Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease. Curr Top Microbiol Immunol 275: 225-248.
3. Palmarini M, Fan H, Sharp JM (1997) Sheep pulmonary adenomatosis: a unique model of retrovirus-associated lung cancer. Trends Microbiol 5: 478-483. (Pubitemid 28020371)
4. Rosenberg N (2001) New transformation tricks from a barnyard retrovirus: implications for human lung cancer. Proc Natl Acad Sci U S A 98: 4285-4287.
5. Wootton SK, Halbert CL, Miller AD (2005) Sheep retrovirus structural protein induces lung tumours. Nature 434: 904-907. (Pubitemid 40559003)
6. Caporale M, Cousens C, Centorame P, Pinoni C, De las Heras M, et al. (2006) Expression of the jaagsiekte sheep retrovirus envelope glycoprotein is sufficient to induce lung tumors in sheep. J Virol 80: 8030-8037. (Pubitemid 44182303)
7. Linnerth-Petrik NM, Santry LA, Yu DL, Wootton SK (2012) Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice. PLoS One 7: e51400.
8. Tsurutani J, Fukuoka J, Tsurutani H, Shih JH, Hewitt SM, et al. (2006) Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol 24: 306-314. (Pubitemid 46622059)
9. Tsurutani J, Steinberg SM, Ballas M, Robertson M, LoPiccolo J, et al. (2007) Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma. Lung Cancer 55: 115-121. (Pubitemid 46038882)
10. Chin YR, Toker A (2009) Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell Signal 21: 470-476.
11. Toker A, Yoeli-Lerner M (2006) Akt signaling and cancer: surviving but not moving on. Cancer Res 66: 3963-3966.
12. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ (2001) Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276: 38349-38352.
13. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, et al. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731. (Pubitemid 32506248)
14. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, et al. (2005) Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25: 1869-1878. (Pubitemid 40280150)
15. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, et al. (2003) Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278: 32124-32131. (Pubitemid 37048402)
16. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004.
17. Chen ML, Xu PZ, Peng XD, Chen WS, Guzman G, et al. (2006) The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice. Genes Dev 20: 1569-1574. (Pubitemid 43901096)
18. Skeen JE, Bhaskar PT, Chen CC, Chen WS, Peng XD, et al. (2006) Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell 10: 269-280. (Pubitemid 44512190)
19. Hollander MC, Maier CR, Hobbs EA, Ashmore AR, Linnoila RI, et al. (2011) Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene 30: 1812-1821.
20. Ju X, Katiyar S, Wang C, Liu M, Jiao X, et al. (2007) Akt1 governs breast cancer progression in vivo. Proc Natl Acad Sci U S A 104: 7438-7443. (Pubitemid 47185924)
21. Maroulakou IG, Oemler W, Naber SP, Tsichlis PN (2007) Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res 67: 167-177. (Pubitemid 46142772)
22. Saji M, Narahara K, McCarty SK, Vasko VV, La Perle KM, et al. (2011) Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer. Oncogene 30: 4307-4315.
23. Xu PZ, Chen ML, Jeon SM, Peng XD, Hay N (2012) The effect Akt2 deletion on tumor development in Pten(+/-) mice. Oncogene 31: 518-526.
24. Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648-657. (Pubitemid 34993700)
25. Potter CJ, Pedraza LG, Xu T (2002) Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4: 658-665. (Pubitemid 34993701)
26. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9: 316-323. (Pubitemid 46344611)
27. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471-484. (Pubitemid 43199434)
28. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.
29. Datta SR, Dudek H, Tao X, Masters S, Fu H, et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241. (Pubitemid 27456390)
30. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868. (Pubitemid 29165088)
31. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
32. Altomare DA, Testa JR (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455-7464. (Pubitemid 41637985)
33. Balsara BR, Pei J, Mitsuuchi Y, Page R, Klein-Szanto A, et al. (2004) Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis 25: 2053-2059. (Pubitemid 39534841)
34. Mukohara T, Kudoh S, Matsuura K, Yamauchi S, Kimura T, et al. (2004) Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC. Anticancer Res 24: 11-17. (Pubitemid 38279683)
35. Tsao AS, McDonnell T, Lam S, Putnam JB, Bekele N, et al. (2003) Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prev 12: 660-664. (Pubitemid 36899849)
36. Sun S, Schiller J, Gazdar A (2007) Lung cancer in never smokers - a different disease. Nat Rev Cancer 7: 778-790. (Pubitemid 47463669)
37. Toh CK, Gao F, Lim WT, Leong SS, Fong KW, et al. (2006) Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 24: 2245-2251. (Pubitemid 46630653)
38. Muscat JE, Wynder EL (1995) Lung cancer pathology in smokers, ex-smokers and never smokers. Cancer Lett 88: 1-5.
39. Ahrendt SA, Decker PA, Alawi EA, Zhu Yr YR, Sanchez-Cespedes M, et al. (2001) Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer 92: 1525-1530. (Pubitemid 32947838)
40. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, et al. (2004) Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 64: 8919-8923. (Pubitemid 39665498)
41. Tam IY, Chung LP, Suen WS, Wang E, Wong MC, et al. (2006) Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res 12: 1647-1653.
42. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, et al. (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97: 339-346. (Pubitemid 40425952)
43. Sharma SV, Bell DW, Settleman J, Haber DA (2007) Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7: 169-181.
44. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, et al. (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97: 339-346. (Pubitemid 40425952)
45. Watson KL, Moorehead RA (2013) Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice. BMC Cancer 13: 375.
46. Novosyadlyy R, Lann DE, Vijayakumar A, Rowzee A, Lazzarino DA, et al. (2010) Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res 70: 741-751.
47. Ferguson RD, Novosyadlyy R, Fierz Y, Alikhani N, Sun H, et al. (2012) Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes. Breast Cancer Res 14: R8.
48. Ferguson RD, Gallagher EJ, Cohen D, Tobin-Hess A, Alikhani N, et al. (2013) Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. Endocr Relat Cancer 20: 391-401.
49. Ferguson RD, Gallagher EJ, Cohen D, Tobin-Hess A, Alikhani N, et al. (2013) Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. Endocr Relat Cancer 20: 391-401.
50. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
51. Sciacca L, Vigneri R, Tumminia A, Frasca F, Squatrito S, et al. (2013) Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients. Nutr Metab Cardiovasc Dis.
52. Colmers IN, Bowker SL, Johnson JA (2012) Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab 38: 475-484.
53. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, et al. (2010) Diabetes and cancer: a consensus report. Diabetes Care 33: 1674-1685.
54. Cohen P, Frame S (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776. (Pubitemid 33679839)
55. Luo J (2009) Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 273: 194-200.
56. Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD (2005) Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res 65: 2076-2081. (Pubitemid 40490111)
57. Bilim V, Ougolkov A, Yuuki K, Naito S, Kawazoe H, et al. (2009) Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma. Br J Cancer 101: 2005-2014.
58. Jiang HL, Xu CX, Kim YK, Arote R, Jere D, et al. (2009) The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft- polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Biomaterials 30: 5844-5852.
59. Xu CX, Jere D, Jin H, Chang SH, Chung YS, et al. (2008) Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med 178: 60-73. (Pubitemid 351919194)
60. Li Y, Liang J, Siu T, Hu E, Rossi MA, et al. (2009) Allosteric inhibitors of Akt1 and Akt2: discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity. Bioorg Med Chem Lett 19: 834-836.
61. Lindsley CW (2010) The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update. Curr Top Med Chem 10: 458-477.
62. Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, et al. (2004) Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10: 828-834. (Pubitemid 39070856)
63. Halbert CL, Allen JM, Miller AD (2002) Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 20: 697-701. (Pubitemid 34734136)
64. Halbert CL, Standaert TA, Aitken ML, Alexander IE, Russell DW, et al. (1997) Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol 71: 5932-5941. (Pubitemid 27304930)
65. Wootton SK, Metzger MJ, Hudkins KL, Alpers CE, York D, et al. (2006) Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV. Retrovirology 3: 94.
66. Greenaway J, Moorehead R, Shaw P, Petrik J (2008) Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. Gynecol Oncol 108: 385-394. (Pubitemid 351174296)